Sale!

KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCNQ2 gene early infantile epileptic encephalopathy type 7 genetic test is a specialized diagnostic tool designed to identify mutations in the KCNQ2 gene, which are associated with early infantile epileptic encephalopathy type 7 (EIEE7). EIEE7 is a severe form of epilepsy that begins in the neonatal period or early infancy, characterized by frequent seizures and significant developmental delays. The KCNQ2 gene plays a crucial role in the proper function of potassium channels in the brain, which are essential for maintaining the electrical balance necessary for normal brain activity.

Conducted at DNA Labs UAE, this genetic test is pivotal for early diagnosis and intervention, offering insights into the specific genetic alterations responsible for the condition. By understanding the genetic basis of the disease, healthcare providers can tailor treatment plans more effectively, potentially improving outcomes for affected infants. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for mutations in the KCNQ2 gene.

The cost of the KCNQ2 gene early infantile epileptic encephalopathy type 7 genetic test at DNA Labs UAE is 4400 AED. While the test represents a significant investment, the information it provides can be invaluable for affected families, enabling access to targeted therapies and support services, and offering a clearer understanding of the condition’s progression and prognosis.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test

At DNA Labs UAE, we offer the KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test at a cost of AED 4400.0.

Test Components and Details

  • Test Name: KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the KCNQ2 Gene Early infantile epileptic encephalopathy type 7 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with KCNQ2 Gene Early infantile epileptic encephalopathy type 7.

About KCNQ2 Gene Early infantile epileptic encephalopathy type 7

KCNQ2 gene is associated with Early Infantile Epileptic Encephalopathy Type 7 (EIEE7), a rare genetic disorder that causes seizures and developmental delays in infants. The KCNQ2 gene plays a crucial role in regulating the flow of charged particles into cells, especially in the brain where it controls the activity of nerve cells.

NGS Genetic Testing

The NGS Genetic Test is a type of genetic testing that utilizes Next-Generation Sequencing technology to analyze multiple genes simultaneously. In the case of KCNQ2 Gene Early infantile epileptic encephalopathy type 7, this test can detect mutations in the KCNQ2 gene that may be responsible for the disorder.

The test involves taking a sample of DNA from the patient’s blood or saliva and sequencing the DNA to identify any changes in the KCNQ2 gene. If a mutation is found, it can help confirm a diagnosis of EIEE7 and guide treatment decisions.

Treatment and Genetic Counseling

Treatment for EIEE7 typically involves medications to control seizures and therapies to support development and improve the quality of life. Genetic testing can also provide important information for family planning and genetic counseling.

Test Name KCNQ2 Gene Early infantile epileptic encephalopathy type 7 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNQ2 Gene Early infantile epileptic encephalopathy type 7 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNQ2 Gene Early infantile epileptic encephalopathy type 7
Test Details

KCNQ2 gene is associated with Early Infantile Epileptic Encephalopathy Type 7 (EIEE7). This is a rare genetic disorder that causes seizures and developmental delays in infants. The KCNQ2 gene provides instructions for making a protein that helps regulate the flow of charged particles (ions) into cells. This protein is particularly important in the brain, where it helps control the activity of nerve cells.

NGS Genetic Test is a type of genetic testing that uses Next-Generation Sequencing technology to analyze multiple genes at once. This test can detect mutations in the KCNQ2 gene that may be responsible for EIEE7. The test involves taking a sample of DNA from the patient’s blood or saliva and sequencing the DNA to look for changes in the KCNQ2 gene.

If a mutation is found in the KCNQ2 gene, it can help confirm a diagnosis of EIEE7 and guide treatment decisions. Treatment for EIEE7 typically involves medications to control seizures and therapies to support development and improve quality of life. Genetic testing can also provide important information for family planning and genetic counseling.